FPE-20972-63170
4 vaccinations
3 coded responses
44 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Pfizer-BioNTech
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-18
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Survey response — day 21, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Prolonged menstruation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
-
2021-05-08
Survey response — day 35, dose 2MedDRA: Dysgeusia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Metallic taste in mouth.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-17
- 2021-07-03
- 2021-10-03
-
2021-10-08
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-08
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-15
- 2021-10-24
- 2021-10-29
- 2021-11-07
- 2021-11-12
- 2021-11-20
-
2022-01-07
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-04-09
-
2022-04-13
Call successfulNot applicable - Accidental Reporting
-
2022-09-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-18
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2022-09-19
- 2022-09-21
- 2022-10-05
- 2022-10-14
- 2022-10-19
- 2022-10-28
- 2022-12-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-14 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 7 — day 21, dose 2
Symptoms: Prolonged menstruation.
Release 8 — day 35, dose 2
Symptoms: Metallic taste in mouth.
Release 10 — 3 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysgeusia | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release